CharlieAJA/iStock via Getty Images
Myriad Genetics (MYG) lost ~20% on Wednesday, on track to record its worst one-day decline in a year, after the molecular diagnostics firm reaffirmed its outlook following its Q1 2026 financials, which fell short of Street forecasts.
The company reported $200.4M
Source link
#Myriad #Genetics #stock #selloff #MYGNNASDAQ
